KO

Healthcare · Pharmaceuticals

Kopran Ltd (KOPRAN)

₹263.16

Mkt cap
₹1,272 Cr
P/E ratio
32.40
P/B
2.41
Div yield
1.14%
ROE
4.91%
ROCE
6.65%
EPS (TTM)
₹8.12
Book value
₹109
52W range
107–296
Sector
Healthcare

Price history

Previous close

Kopran Ltd. is a fully integrated pharmaceutical company that manufactures and supplies high-quality formulations and active pharmaceutical ingredients globally.

NSE KOPRANBSE 524280
Health check
Cautious
ValuationFair
ProfitabilityWeak
GrowthModerate
TechnicalsNeutral
52-week range
−11.04% from high
₹263
₹107+145.94% from low₹296
Current
₹263.16
Prev close
₹267.05
Day
−1.46%
Price performance
1D
−0.99%
1W
−8.53%
1M
+1.05%
3M
+32.39%
6M
+58.09%
1Y
+85.06%
YTD
+73.04%

Financials

Revenue, profit & margin
P/E ratio
32.4×
KOPRAN is 0% below the sector median of 32.5×
KOPRAN32.4×
Sector median32.5×
 Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Trend
Sales152.59158.92186.08139.44151.56166.24172.36135.22117.91194.28234.02153.99211.26
YoY Sales growth+30.45%+0.58%+24.99%+19.18%-0.68%+4.61%-7.37%-3.03%-22.20%+16.87%+35.77%+13.88%+79.17%
Expenses129.76135.34164.39121.28136.83146.39155.27121.09123.19176.52201.08138.18195.85
Operating Profit22.8323.5821.6918.1614.7319.8517.0914.13-5.2817.7632.9415.8115.41
OPM %14.96%14.84%11.66%13.02%9.72%11.94%9.92%10.45%-4.48%9.14%14.08%10.27%7.29%
Other Income0.132.439.672.631.000.173.262.560.030.070.092.050.62
Interest1.942.242.592.182.232.162.772.542.092.673.173.284.25
Depreciation2.773.273.593.873.854.003.874.264.284.424.525.775.89
Profit before tax18.2520.5025.1814.749.6513.8613.719.89-11.6210.7425.348.815.89
Tax %24.55%23.02%26.01%24.69%23.42%24.96%29.39%24.67%-14.63%13.04%25.57%23.84%25.47%
Net Profit13.7715.7918.6211.107.3810.409.687.45-9.929.3418.876.704.39
EPS in Rs2.863.283.862.301.532.162.011.54-2.061.943.911.390.91
Raw PDF

Earnings

Results dates & reactions
No upcoming results date on calendar.

Fresh quarters land in the Financials table above, tagged NSE until screener catches up.

Avg earnings-day move −1.66% · closed higher next day 1 of last 2
 Q1FY27Q2FY27
Broadcast7 Aug '263 Nov '26
Earnings day−4.95%+1.63%
+1 day−6.79%+2.99%
+5 days−0.24%+8.95%
+15 days+5.82%—
+30 days+48.42%—
FilingXBRLXBRL

Corporate actions

Last 6 months

No recent corporate actions

Dividends, splits, and bonuses in the last six months show up here.

Shareholding

as of Sep 2026
41.83%Promoter
Promoters41.83%2.60
FIIs0.91%0.40
DIIs0.00%
Public57.26%2.20
Ownership trend

Peers

8 companies
Valuation vs quality
P/E × ROCE · bubble = market cap
NameCMPP/EMkt CapDiv YldNP QtrQtr Profit VarSales QtrQtr Sales VarROCE
Sun Pharma.Inds.₹1,884.9036.764,52,2510.85%1,995−10.53%16,199+11.88%20.53%
Divi's Lab.₹11,180.5086.862,96,8070.27%1,127+63.57%3,676+35.40%21.97%
Torrent Pharma.₹4,689.5082.161,78,3740.81%534−10.03%4,979+50.79%15.19%
Laurus Labs₹2,294.6092.531,23,9800.09%436+126.43%2,206+33.44%17.76%
Zydus Lifesci.₹1,200.0026.421,19,7000.08%928−27.96%7,910+29.17%21.14%
Dr Reddy's Labs₹1,390.2041.471,16,1190.58%913−31.35%8,698−1.48%13.04%
Cipla₹1,415.0036.811,14,3160.92%852−35.05%7,404−2.44%15.49%
Kopran₹263.1632.361,2721.14%4+144.25%211+79.17%6.65%
Median: 160 Co.₹432.2032.471,9830.08%13+33.73%179+21.23%14.94%

Filings